{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:43:52Z","timestamp":1777880632821,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1757-2215-7-4","type":"journal-article","created":{"date-parts":[[2014,1,10]],"date-time":"2014-01-10T16:34:35Z","timestamp":1389371675000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Inhibitory effects of aromatase inhibitor on estrogen receptor-alpha positive ovarian cancer in mice"],"prefix":"10.1186","volume":"7","author":[{"given":"Hachidai","family":"Hirakawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihito","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidemi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Mizunuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,1,10]]},"reference":[{"issue":"1","key":"220_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A: Cancer statistics, 2013. CA Cancer J Clin 2013,63(1):11\u201330. 10.3322\/caac.21166","journal-title":"CA Cancer J Clin"},{"issue":"3\u20134","key":"220_CR2","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0960-0760(94)90019-1","volume":"50","author":"SP Langdon","year":"1994","unstructured":"Langdon SP, Hirst GL, Miller EP, Hawkins RA, Tesdale AL, Smyth JF, Miller WR: The regulation of growth and protein expression by estrogen in vitro : a study of 8 human ovarian carcinoma cell lines. J Steroid Biochem Mol Biol 1994,50(3\u20134):131\u2013135.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"5","key":"220_CR3","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/0959-8049(94)90545-2","volume":"30A","author":"SP Langdon","year":"1994","unstructured":"Langdon SP, Crew AJ, Ritchie AA, Muir M, Wakeling A, Smyth JF, Miller WR: Growth inhibition of oestrogen receptor-positive human ovarian carcinoma by anti-oestrogens in vitro and in a xenograft model. Eur J Cancer 1994,30A(5):682\u2013686.","journal-title":"Eur J Cancer"},{"issue":"9","key":"220_CR4","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1158\/1078-0432.CCR-08-2525","volume":"15","author":"GN Armaiz-Pena","year":"2009","unstructured":"Armaiz-Pena GN, Mangala LS, Spannuth WA, Lin YG, Jennings NB, Nick AM, Langley RR, Schmandt R, Lutgendorf SK, Cole SW, Sood AK: Estrous cycle modulates ovarian carcinoma growth. Clin Cancer Res 2009,15(9):2971\u20132978. 10.1158\/1078-0432.CCR-08-2525","journal-title":"Clin Cancer Res"},{"issue":"21","key":"220_CR5","doi-asserted-by":"publisher","first-page":"5911","DOI":"10.1158\/1078-0432.CCR-12-1257","volume":"18","author":"F Simpkins","year":"2012","unstructured":"Simpkins F, Hevia-Paez P, Sun J, Ullmer W, Gilbert CA, da Silva T, Pedram A, Levin ER, Reis IM, Rabinovich B, Azzam D, Xu XX, Ince TA, Yang JY, Verhaak RG, Lu Y, Mills GB, Slingerland JM: Src inhibition with saracatinib reverses fulvestrant resistance in ER-positive ovarian cancer models in vitro and in vivo . Clin Cancer Res 2012,18(21):5911\u20135923. 10.1158\/1078-0432.CCR-12-1257","journal-title":"Clin Cancer Res"},{"issue":"6","key":"220_CR6","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.steroids.2013.01.008","volume":"78","author":"F Simpkins","year":"2013","unstructured":"Simpkins F, Garcia-Soto A, Slingerland J: New insights on the role of hormonal therapy in ovarian cancer. Steroids 2013,78(6):530\u2013537. 10.1016\/j.steroids.2013.01.008","journal-title":"Steroids"},{"issue":"23","key":"220_CR7","first-page":"5367","volume":"58","author":"P Pujol","year":"1998","unstructured":"Pujol P, Rey JM, Nirde P, Roger P, Gastaldi M, Laffargue F, Rochefort H, Maudelonde T: Differential expression of estrogen receptor-alpha and -beta messenger RNAs as a potential marker of ovarian carcinogenesis. Cancer Res 1998,58(23):5367\u20135373.","journal-title":"Cancer Res"},{"issue":"16","key":"220_CR8","doi-asserted-by":"publisher","first-page":"5861","DOI":"10.1158\/0008-5472.CAN-04-0552","volume":"64","author":"A Bardin","year":"2004","unstructured":"Bardin A, Hoffmann P, Boulle N, Katsaros D, Vignon F, Pujol P, Lazennec G: Involvement of estrogen receptor beta in ovarian carcinogenesis. Cancer Res 2004,64(16):5861\u20135869. 10.1158\/0008-5472.CAN-04-0552","journal-title":"Cancer Res"},{"issue":"4","key":"220_CR9","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1677\/erc.1.01039","volume":"12","author":"AJ O\u2019Donnell","year":"2005","unstructured":"O\u2019Donnell AJ, Macleod KG, Burns DJ, Smyth JF, Langdon SP: Estrogen receptor-alpha mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen. Endocr Relat Cancer 2005,12(4):851\u2013866. 10.1677\/erc.1.01039","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"220_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jsbmb.2004.10.021","volume":"93","author":"S Cunat","year":"2005","unstructured":"Cunat S, Rabenoelina F, Daur\u00e8s JP, Katsaros D, Sasano H, Miller WR, Maudelonde T, Pujol P: Aromatase expression in ovarian epithelial cancers. J Steroid Biochem Mol Biol 2005,93(1):15\u201324. 10.1016\/j.jsbmb.2004.10.021","journal-title":"J Steroid Biochem Mol Biol"},{"key":"220_CR11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1749-6632.1995.tb17369.x","volume":"774","author":"F Labrie","year":"1995","unstructured":"Labrie F, Belanger A, Simard J, Van L, Labrie C: DHEA and peripheral androgen and estrogen formation: intracinology. Ann N Y Acad Sci 1995, 774: 16\u201328. 10.1111\/j.1749-6632.1995.tb17369.x","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"220_CR12","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/0090-8258(89)90607-0","volume":"33","author":"BJ Slotman","year":"1989","unstructured":"Slotman BJ, Kuhnel R, Rao BR, Dijkhuizen GH, De GJ, Stolk JG: Importance of steroid receptors and aromatase activity in the prognosis of ovarian cancer: high tumor progesterone receptor levels correlate with longer survival. Gynecol Oncol 1989,33(1):76\u201381. 10.1016\/0090-8258(89)90607-0","journal-title":"Gynecol Oncol"},{"issue":"1","key":"220_CR13","first-page":"91","volume":"16","author":"J Kitawaki","year":"1996","unstructured":"Kitawaki J, Noguchi T, Yamamoto T, Yokota K, Maeda K, Urabe M, Honjo H: Immunohistochemical localisation of aromatase and its correlation with progesterone receptors in ovarian epithelial tumours. Anticancer Res 1996,16(1):91\u201397.","journal-title":"Anticancer Res"},{"issue":"1","key":"220_CR14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/sj.bjc.6601508","volume":"90","author":"ZW Wong","year":"2004","unstructured":"Wong ZW, Ellis MJ: First-line endocrine treatment of breast cancer: aromatase inhibitor or antioestrogen? Br J Cancer 2004,90(1):20\u201325. 10.1038\/sj.bjc.6601508","journal-title":"Br J Cancer"},{"issue":"2","key":"220_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1677\/erc.0.0060197","volume":"6","author":"H Sasano","year":"1999","unstructured":"Sasano H, Sato S, Ito K, Yajima A, Nakamura J, Yoshihama M, Ariga K, Anderson TJ, Miller WR: Effects of aromatase inhibitors on the pathobiology of the human breast, endometrial and ovarian carcinoma. Endocr Relat Cancer 1999,6(2):197\u2013204. 10.1677\/erc.0.0060197","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"220_CR16","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1158\/1535-7163.MCT-06-0722","volume":"6","author":"Y Yokoyama","year":"2007","unstructured":"Yokoyama Y, Xin B, Shigeto T, Umemoto M, Kasai-Sakamoto A, Futagami M, Tsuchida S, Al-Mulla F, Mizunuma H: Clofibric acid, a peroxisome proliferator\u2013activated receptor \u03b1 ligand, inhibits growth of human ovarian cancer. Mol Cancer Ther 2007,6(4):1379\u20131386. 10.1158\/1535-7163.MCT-06-0722","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"220_CR17","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neures.2012.11.007","volume":"75","author":"P Meng","year":"2013","unstructured":"Meng P, Yoshida H, Matsumiya T, Imaizumi T, Tanji K, Xing F, Hayakari R, Dempoya J, Tatsuta T, Aizawa-Yashiro T, Mimura J, Kosaka K, Itoh K, Satoh K: Carnosic acid suppresses the production of amyloid-\u03b2 1\u201342 by inducing the metalloprotease gene TACE\/ADAM17 in SH-SY5Y human neuroblastoma cells. Neurosci Res 2013,75(2):94\u2013102. 10.1016\/j.neures.2012.11.007","journal-title":"Neurosci Res"},{"issue":"4","key":"220_CR18","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/sj.bjc.6602009","volume":"91","author":"A Sakamoto","year":"2004","unstructured":"Sakamoto A, Yokoyama Y, Umemoto M, Futagami M, Sakamoto T, Bing X, Mizunuma H: Clinical implication of expression of cyclooxygenase-2 and peroxisome proliferator activated-receptor gamma in epithelial ovarian tumours. Br J Cancer 2004,91(4):633\u2013638.","journal-title":"Br J Cancer"},{"issue":"10","key":"220_CR19","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1136\/jcp.2009.065169","volume":"62","author":"M Rayoo","year":"2009","unstructured":"Rayoo M, Yan M, Takano EA, Bates GJ, Brown PJ, Banham AH, Fox SB: Expression of the forkhead box transcription factor FOXP1 is associated with oestrogen receptor alpha, oestrogen receptor beta and improved survival in familial breast cancers. J Clin Pathol 2009,62(10):896\u2013902. 10.1136\/jcp.2009.065169","journal-title":"J Clin Pathol"},{"issue":"4","key":"220_CR20","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/ijc.11398","volume":"107","author":"C Dabrosin","year":"2003","unstructured":"Dabrosin C, Margetts PJ, Gauldie J: Estradiol increases extracellular levels of vascular endothelial growth factor in vivo in murine mammary cancer. Int J Cancer 2003,107(4):535\u2013540. 10.1002\/ijc.11398","journal-title":"Int J Cancer"},{"issue":"12","key":"220_CR21","first-page":"3183","volume":"60","author":"SM Hyder","year":"2000","unstructured":"Hyder SM, Nawaz Z, Chiappetta C, Stancel GM: Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor. Cancer Res 2000,60(12):3183\u20133190.","journal-title":"Cancer Res"},{"issue":"12","key":"220_CR22","doi-asserted-by":"crossref","first-page":"5589","DOI":"10.1210\/endo.137.12.8940388","volume":"137","author":"J Nakamura","year":"1996","unstructured":"Nakamura J, Savinov A, Lu Q, Brodie A: Estrogen regulates vascular endothelial growth\/permeability factor expression in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors. Endocrinology 1996,137(12):5589\u20135596.","journal-title":"Endocrinology"},{"issue":"6","key":"220_CR23","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1210\/endo-100-6-1684","volume":"100","author":"AM Brodie","year":"1977","unstructured":"Brodie AM, Schwarzel WC, Shaikh AA, Brodie HJ: The effect of an aromatase inhibitor, 4-hydroxy-4-androstene-3,17-dione, on estrogen-dependent processes in reproduction and breast cancer. Endocrinology 1977,100(6):1684\u20131695. 10.1210\/endo-100-6-1684","journal-title":"Endocrinology"},{"issue":"1","key":"220_CR24","first-page":"45","volume":"25","author":"N Fersis","year":"2004","unstructured":"Fersis N, Smyczek-Gargya B, Armeanu S, Gagulic E, Pantic L, Relakis K, Friedrich M, Wallwiener D: Changes in vascular endothelial growth factor (VEGF) after chemoendocrine therapy in breast cancer. Eur J Gynaecol Oncol 2004,25(1):45\u201350.","journal-title":"Eur J Gynaecol Oncol"},{"issue":"1","key":"220_CR25","first-page":"317","volume":"42","author":"E Coezy","year":"1982","unstructured":"Coezy E, Borgna JL, Rochefort H: Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth. Cancer Res 1982,42(1):317\u2013323.","journal-title":"Cancer Res"},{"issue":"4","key":"220_CR26","doi-asserted-by":"publisher","first-page":"R56","DOI":"10.1186\/bcr2113","volume":"10","author":"J Lisztwan","year":"2008","unstructured":"Lisztwan J, Pornon A, Chen B, Chen S, Evans DB: The aromatase inhibitor letrozole and inhibitors of insulin-like growth factor I receptor synergistically induce apoptosis in in vitro models of estrogen-dependent breast cancer. Breast Cancer Res 2008,10(4):R56. 10.1186\/bcr2113 10.1186\/bcr2113","journal-title":"Breast Cancer Res"},{"key":"220_CR27","unstructured":"Liu Y, Zhang X, Liu J, Hou G, Zhang S, Zhang J: Everolimus in combination with letrozole inhibit human breast cancer MCF-7\/Aro stem cells via PI3K\/mTOR pathway: an experimental study. Tumour Biol in press"},{"issue":"11","key":"220_CR28","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1007\/s10495-013-0879-6","volume":"18","author":"C Amaral","year":"2013","unstructured":"Amaral C, Varela C, Borges M, Tavares da Silva E, Roleira FM, Correia-da-Silva G, Teixeira N: Steroidal aromatase inhibitors inhibit growth of hormone-dependent breast cancer cells by inducing cell cycle arrest and apoptosis. Apoptosis 2013,18(11):1426\u20131436. 10.1007\/s10495-013-0879-6","journal-title":"Apoptosis"},{"issue":"44","key":"220_CR29","doi-asserted-by":"publisher","first-page":"18060","DOI":"10.1073\/pnas.1018858109","volume":"109","author":"ST Bailey","year":"2012","unstructured":"Bailey ST, Shin H, Westerling T, Liu XS, Brown M: Estrogen receptor prevents p53-dependent apoptosis in breast cancer. Proc Natl Acad Sci USA 2012,109(44):18060\u201318065. 10.1073\/pnas.1018858109","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"220_CR30","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/S1470-2045(10)70257-6","volume":"11","author":"J Cuzick","year":"2010","unstructured":"Cuzick J, Sestak I, Baum M, Buzdar A, Howell A, Dowsett M, Forbes JF: Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. Lancet Oncol 2010,11(12):1135\u20131141. 10.1016\/S1470-2045(10)70257-6","journal-title":"Lancet Oncol"},{"issue":"1","key":"220_CR31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ygyno.2008.03.014","volume":"110","author":"PT Ramirez","year":"2008","unstructured":"Ramirez PT, Schmeler KM, Milam MR, Slomovitz BM, Smith JA, Kavanagh JJ, Deavers M, Levenback C, Coleman RL, Gershenson DM: Efficacy of letrozole in the treatment of recurrent platinum- and taxane-resistant high-grade cancer of the ovary or peritoneum. Gynecol Oncol 2008,110(1):56\u201359. 10.1016\/j.ygyno.2008.03.014","journal-title":"Gynecol Oncol"},{"issue":"12","key":"220_CR32","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.1158\/1078-0432.CCR-06-2878","volume":"13","author":"JF Smyth","year":"2007","unstructured":"Smyth JF, Gourley C, Walker G, MacKean MJ, Stevenson A, Williams AR, Nafussi AA, Rye T, Rye R, Stewart M, McCurdy J, Mano M, Reed N, McMahon T, Vasey P, Gabra H, Langdon SP: Antiestrogen therapy is active in selected ovarian cancer cases: the use of letrozole in estrogen receptor-positive patients. Clin Cancer Res 2007,13(12):3617\u20133622. 10.1158\/1078-0432.CCR-06-2878","journal-title":"Clin Cancer Res"},{"issue":"2","key":"220_CR33","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1159\/000077436","volume":"66","author":"CA Papadimitriou","year":"2004","unstructured":"Papadimitriou CA, Markaki S, Siapkaras J, Vlachos G, Efstathiou E, Grimani I, Hamilos G, Zorzou M, Dimopoulos MA: Hormonal therapy with letrozole for relapsed epithelial ovarian cancer. Long-term results of a phase II study. Oncology 2004,66(2):112\u2013117. 10.1159\/000077436","journal-title":"Oncology"},{"issue":"7","key":"220_CR34","first-page":"2233","volume":"8","author":"A Bowman","year":"2002","unstructured":"Bowman A, Gabra H, Langdon SP, Lessells A, Stewart M, Young A, Smyth JF: CA125 response is associated with estrogen receptor expression in a phase II trial of letrozole in ovarian cancer: identification of an endocrine-sensitive subgroup. Clin Cancer Res 2002,8(7):2233\u20132239.","journal-title":"Clin Cancer Res"},{"issue":"11","key":"220_CR35","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1158\/0008-5472.CAN-11-3287","volume":"72","author":"V Iyer","year":"2012","unstructured":"Iyer V, Klebba I, McCready J, Arendt LM, Betancur-Boissel M, Wu MF, Zhang X, Lewis MT, Kuperwasser C: Estrogen promotes ER-negative tumor growth and angiogenesis through mobilization of bone marrow-derived monocytes. Cancer Res 2012,72(11):2705\u20132713. 10.1158\/0008-5472.CAN-11-3287","journal-title":"Cancer Res"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1757-2215-7-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T22:32:40Z","timestamp":1630708360000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/1757-2215-7-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,10]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["220"],"URL":"https:\/\/doi.org\/10.1186\/1757-2215-7-4","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,10]]},"assertion":[{"value":"10 November 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"4"}}